Gangwon Innovation Center and Boditech Med Pursue Open Innovation Partnership
The Gangwon Center for Creative Economy & Innovation (GCCEI) and Boditech Med, a company specializing in in vitro diagnostic medical devices, are preparing a special opportunity for innovative startups. We are launching an 'Open Innovation'...
Editorial context: This article is part of Startup Korea's original market analysis coverage. It is written to explain startup trends, business model risks, and technology adoption signals for general information, not as investment advice.
The Gangwon Center for Creative Economy & Innovation (GCCEI) and Boditech Med, a company specializing in in vitro diagnostic medical devices, are preparing a special opportunity for innovative startups.
We are launching an 'Open Innovation' program aimed at discovering bio/health startups that possess outstanding technology and services in the field of in vitro diagnostics and medical devices, and fostering co-growth through collaboration with the global company Boditech Med.
Eligible participants are bio/health startups within 10 years of establishment, and they can apply with their innovative ideas without regional restrictions.
Selected companies will receive a collaboration project support fund of up to 10 million won if verification is needed. Additionally, by being registered as a nurtured company of the Gangwon Innovation Center, they can utilize various startup support programs, and receive broad support from Boditech Med, including opportunities for investment review, R&D commercialization, and joint research and development.
Through this collaboration, we aim to provide a stepping stone for promising startups to take another leap forward. We look forward to the active participation of capable startups!
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0